Li, Xuefei
Tongji University · Shanghai Pulmonary Hospital
7 papers on CoChatORCID 0000-0002-4119-4652
Most cited papers
- Verified
TIM-3, a promising target for cancer immunotherapy
He, Y., Cao, J., Zhao, C., Li, X., Zhou, C., & Hirsch, F. (2018) · OncoTargets and Therapy
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 235
- Verified
Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?
Qiao, M., Jiang, T., Liu, X., Mao, S., Zhou, F., Li, X., Zhao, C., Chen, X., Su, C., Ren, S., et al. (2021) · Journal of Thoracic Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 186
- Verified
EGFR‐targeted therapy alters the tumor microenvironment in EGFR‐driven lung tumors: Implications for combination therapies
Jia, Y., Li, X., Jiang, T., Zhao, S., Zhao, C., Zhang, L., Liu, X., Shi, J., Qiao, M., Luo, J., et al. (2019) · International Journal of Cancer
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 164
- Verified
Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
Zhao, S., Gao, G., Li, W., Li, X., Zhao, C., Jiang, T., Jia, Y., He, Y., Li, A., Su, C., et al. (2019) · Lung Cancer
Cancer Immunotherapy and BiomarkersGut microbiota and health
Cited by 164
- Verified
New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment
Sun, F., Zheng, Z., Lan, J., Li, X., Li, M., Song, K., & Wu, X. (2019) · Drug Delivery
Advanced Drug Delivery SystemsDrug Solubulity and Delivery Systems
Cited by 85
- Verified
Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy
Shi, J., Department of Medical Oncology, S. P. H. &. T. C. I., Yang, H., Jiang, T., Li, X., Zhao, C., Zhang, L., Zhao, S., Liu, X., Jia, Y., et al. (2017) · Chinese Journal of Cancer Research
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 37
- Verified
Rebaudioside A/TPGS mixed nanomicelles as promising nanocarriers for nimodipine ocular delivery
Li, X., Fang, J., Xin, M., Li, Q., Wang, J., Yang, H., & Wu, X. (2021) · Drug Delivery and Translational Research
Advanced Drug Delivery SystemsDrug Solubulity and Delivery Systems
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free